Molecules/POZELIMAB

POZELIMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Complement C5 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

POZELIMABPOZELIMAB-BBFGREGN-3918REGN3918VEOPOZ

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to POZELIMAB

Loading drug network...